Modulation of mdrl expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance
1996
Cytokines and Multidrug Resistance in Colon Cancer
publication
Evidence: moderate
Author Information
Author(s): U Stein, W Walther, RH Shoemaker
Primary Institution: National Cancer Institute
Hypothesis
Can cytokines modulate multidrug resistance in colon carcinoma cells?
Conclusion
Cytokines can effectively reverse multidrug resistance in colon carcinoma cells, enhancing their sensitivity to chemotherapy.
Supporting Evidence
- Cytokines TNFa, IL-2, and IFNy were shown to decrease mdrl expression in colon carcinoma cells.
- Cytokine treatment enhanced the accumulation of doxorubicin in resistant cancer cells.
- The maximum effect of cytokine treatment on mdrl expression was observed after 48 hours.
Takeaway
Cytokines can help cancer cells respond better to treatment by making them less resistant to drugs.
Methodology
The study used RT-PCR and flow cytometry to analyze the effects of cytokines on mdrl expression and P-glycoprotein function in colon carcinoma cell lines.
Limitations
The study primarily focused on in vitro models, and results may not directly translate to in vivo conditions.
Statistical Information
P-Value
p<0.0004
Statistical Significance
p<0.0004
Want to read the original?
Access the complete publication on the publisher's website